市場調查報告書

腫瘤切除:全球市場的展望(2018年∼2027年)

Tumor Ablation - Global Market Outlook (2018-2027)

出版商 Stratistics Market Research Consulting 商品編碼 928584
出版日期 內容資訊 英文 156 Pages
商品交期: 2-3個工作天內
價格
腫瘤切除:全球市場的展望(2018年∼2027年) Tumor Ablation - Global Market Outlook (2018-2027)
出版日期: 2020年02月20日內容資訊: 英文 156 Pages
簡介

全球腫瘤切除市場在2018年估算為3億9466萬美金。該市場在預測期間內預計將以13.7%的年複合成長率增長,2027年達到12億5,333萬美元的規模。影響該市場成長的主要原因有切除技術的技術進步,全球老年人口增加,癌症的發生率增加,醫院,外科及切除中心數的增加。然而嚴格的法規流程,阻礙了該市場的成長。

本報告提供全球腫瘤切除市場的相關調查,提供市場趨勢和威脅,成長及阻礙因素,各治療·功能·技術·用途·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 簡介

第3章 市場趨勢分析

  • 簡介
  • 成長要素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 技術分析
  • 用途分析
  • 終端用戶分析
  • 新興市場
  • 今後的市場方案

第4章 波特的五力分析

第5章 全球市場:不同治療

  • 簡介
  • 腹腔鏡切除
  • 外科切除
  • 經皮切除

第6章 全球市場:各功能

  • 簡介
  • 傳統切除設備
  • 自動化/機器人切除

第7章 全球市場:各技術

  • 簡介
  • 影像指導產品
    • 磁振造影(MRI)
    • 電腦斷層攝影
  • 腫瘤切除系統
    • 冷凍切除
    • 微波切除系統
    • 射頻消融術系統(RFA)
    • 不可逆電力穿孔切除
    • 高能聚焦超音波療法
    • 雷射間品質溫熱切除
    • 溫熱切除
  • 導管·探針

第8章 全球市場:各用途

  • 簡介
  • 肝臟癌症
  • 前列腺癌症
  • 肺癌症
  • 乳癌
  • 腎臟癌症
  • 骨轉移
  • 腦癌症
  • 胰臟癌症
  • 疼痛緩和
  • 頭頸椎癌症

第9章 全球市場:各終端用戶

  • 簡介
  • 腫瘤診所
  • 調查機關
  • 癌症專門中心
  • 醫院
  • 外科·切除中心
  • 診斷中心

第10章 全球市場: 各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他

第11章 主要開發

  • 契約,展開,合作,合資企業
  • 收購·合併
  • 新產品的銷售
  • 擴張
  • 其他主要策略

第12章 企業簡介

  • INTIO Inc.
  • Medtronic PLC
  • Galil Medical, Inc.
  • Sonacare Medical
  • AngioDynamics, Inc.
  • NeuWave Medical
  • EDAP TMS S.A.
  • Healthtronics, Inc.
  • Ethicon, Inc.
  • Koninklijke Philips N.V
  • Misonix, Inc.
  • IceCure Medical Ltd.
  • Boston Scientific Corporation
  • ERBE Elektromedizin GmbH
  • CooperSurgical Inc.
  • Mermaid Medical
  • Endocare Inc.
  • B V M Meditech Private Limited
目錄

According to Stratistics MRC, the Global Tumor Ablation Market is accounted for $394.66 million in 2018 and is expected to reach $1,253.33 million by 2027 growing at a CAGR of 13.7% during the forecast period. Some of the key factors influencing the market growth include technological advancements in the thermal ablation techniques, growing geriatric population across the world, increasing incidence of cancer and sprouting number of hospitals, surgical, and ablation centres. However, the strict regulatory process is restraining market growth.

Tumor ablation is a minimally invasive image-guided technique used in the treatment of the tumors in the liver, kidney, soft tissue and bone. It ensures high efficacy of tumor treatment with minimal side effects by using heat, chemicals and low temperature. It uses an array of parallel alternating electrodes to deliver radiofrequency energy that heats the lining of the gastrointestinal tract, destroying the cancerous or infected tissue. Tumor ablation has primarily been used for the treatment of oesophagal squamous cell dysplasia, gastric antral vascular ectasia, radiation proctopathy, cholangiocarcinoma, and pancreatic neoplasia.

Based on the technology, radiofrequency ablation system (RFA) is expected to grow at a significant rate during the forecast period, due to its ease of treatment (as compared to open surgical procedure), its proven clinical efficacy and safety profile, and ongoing developments & commercialization of technologically advanced radiofrequency tumor ablation systems. Radiofrequency ablation uses high-energy radio waves for treatment, in which a thin, needle-like probe is inserted into the tumor. RFA is more effective in hepatocellular carcinoma (HCC), the most common primary liver neoplasia with a poor diagnosis.

By geography, North America is likely to have a huge demand owing to high prevalence and incidence of major types of cancer (such as liver, lung, kidney, and bone metastasis) in the region, rising inclination of patients towards minimally invasive procedures for cancer treatment, and increasing government funding for cancer research. The growing investments of many key players in this market have grown significantly in the United States. Besides, the focus on the development of products with innovative features and greater effectiveness has increased in recent times. As a result, there has been a rise in R&D funds.

Some of the key players in global tumor ablation market are INTIO Inc., Medtronic PLC, Galil Medical, Inc., Sonacare Medical, AngioDynamics, Inc., NeuWave Medical, EDAP TMS S.A., Healthtronics, Inc., Ethicon, Inc., Koninklijke Philips N.V, Misonix, Inc., IceCure Medical Ltd., Boston Scientific Corporation, ERBE Elektromedizin GmbH, CooperSurgical Inc., Mermaid Medical, Endocare Inc., and B V M Meditech Private Limited.

Treatments Covered:

  • Laparoscopic ablation
  • Surgical ablation
  • Percutaneous ablation

Functions Covered:

  • Conventional ablation devices
  • Automated/Robotic ablation

Technologies Covered:

  • Image Guidance Products
  • Tumor Ablation Systems
  • Catheters or Probes

Applications Covered:

  • Liver cancer
  • Prostate cancer
  • Lung cancer
  • Breast cancer
  • Kidney cancer
  • Bone Metastasis
  • Brain Cancer
  • Pancreatic Cancer
  • Pain palliation
  • ENT Cancer

End Users Covered:

  • Oncology Clinics
  • Research Institutes
  • Cancer Specialty Centers
  • Hospitals
  • Surgical and Ablation Centers
  • Diagnostic Centres

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Tumor Ablation Market, By Treatment

  • 5.1 Introduction
  • 5.2 Laparoscopic Ablation
  • 5.3 Surgical Ablation
  • 5.4 Percutaneous Ablation

6 Global Tumor Ablation Market, By Function

  • 6.1 Introduction
  • 6.2 Conventional ablation devices
  • 6.3 Automated/Robotic ablation

7 Global Tumor Ablation Market, By Technology

  • 7.1 Introduction
  • 7.2 Image Guidance Products
    • 7.2.1 Magnetic Resonance Imaging (MRI)
    • 7.2.2 Computed Tomography
  • 7.3 Tumor Ablation Systems
    • 7.3.1 Cryoablation
    • 7.3.2 Microwave Ablation System
    • 7.3.3 Radiofrequency Ablation System (RFA)
    • 7.3.4 Irreversible Electroporation Ablation
    • 7.3.5 High Intensity Focused Ultrasound
    • 7.3.6 Laser Interstitial Thermal Ablation
    • 7.3.7 Hyperthermic ablation
  • 7.4 Catheters or Probes

8 Global Tumor Ablation Market, By Application

  • 8.1 Introduction
  • 8.2 Liver cancer
  • 8.3 Prostate cancer
  • 8.4 Lung cancer
  • 8.5 Breast cancer
  • 8.6 Kidney cancer
  • 8.7 Bone Metastasis
  • 8.8 Brain Cancer
  • 8.9 Pancreatic Cancer
  • 8.10 Pain palliation
  • 8.11 ENT Cancer

9 Global Tumor Ablation Market, By End User

  • 9.1 Introduction
  • 9.2 Oncology Clinics
  • 9.3 Research Institutes
  • 9.4 Cancer Specialty Centers
  • 9.5 Hospitals
  • 9.6 Surgical and Ablation Centers
  • 9.7 Diagnostic Centres

10 Global Tumor Ablation Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 INTIO Inc.
  • 12.2 Medtronic PLC
  • 12.3 Galil Medical, Inc.
  • 12.4 Sonacare Medical
  • 12.5 AngioDynamics, Inc.
  • 12.6 NeuWave Medical
  • 12.7 EDAP TMS S.A.
  • 12.8 Healthtronics, Inc.
  • 12.9 Ethicon, Inc.
  • 12.10 Koninklijke Philips N.V
  • 12.11 Misonix, Inc.
  • 12.12 IceCure Medical Ltd.
  • 12.13 Boston Scientific Corporation
  • 12.14 ERBE Elektromedizin GmbH
  • 12.15 CooperSurgical Inc.
  • 12.16 Mermaid Medical
  • 12.17 Endocare Inc.
  • 12.18 B V M Meditech Private Limited

List of Tables

  • Table 1 Global Tumor Ablation Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Tumor Ablation Market Outlook, By Treatment (2017-2027) ($MN)
  • Table 3 Global Tumor Ablation Market Outlook, By Laparoscopic Ablation (2017-2027) ($MN)
  • Table 4 Global Tumor Ablation Market Outlook, By Surgical Ablation (2017-2027) ($MN)
  • Table 5 Global Tumor Ablation Market Outlook, By Percutaneous Ablation (2017-2027) ($MN)
  • Table 6 Global Tumor Ablation Market Outlook, By Function (2017-2027) ($MN)
  • Table 7 Global Tumor Ablation Market Outlook, By Conventional ablation devices (2017-2027) ($MN)
  • Table 8 Global Tumor Ablation Market Outlook, By Automated/Robotic ablation (2017-2027) ($MN)
  • Table 9 Global Tumor Ablation Market Outlook, By Technology (2017-2027) ($MN)
  • Table 10 Global Tumor Ablation Market Outlook, By Image Guidance Products (2017-2027) ($MN)
  • Table 11 Global Tumor Ablation Market Outlook, By Magnetic Resonance Imaging (MRI) (2017-2027) ($MN)
  • Table 12 Global Tumor Ablation Market Outlook, By Computed Tomography (2017-2027) ($MN)
  • Table 13 Global Tumor Ablation Market Outlook, By Tumor Ablation Systems (2017-2027) ($MN)
  • Table 14 Global Tumor Ablation Market Outlook, By Cryoablation (2017-2027) ($MN)
  • Table 15 Global Tumor Ablation Market Outlook, By Microwave Ablation System (2017-2027) ($MN)
  • Table 16 Global Tumor Ablation Market Outlook, By Radiofrequency Ablation System (RFA) (2017-2027) ($MN)
  • Table 17 Global Tumor Ablation Market Outlook, By Irreversible Electroporation Ablation (2017-2027) ($MN)
  • Table 18 Global Tumor Ablation Market Outlook, By High Intensity Focused Ultrasound (2017-2027) ($MN)
  • Table 19 Global Tumor Ablation Market Outlook, By Laser Interstitial Thermal Ablation (2017-2027) ($MN)
  • Table 20 Global Tumor Ablation Market Outlook, By Hyperthermic ablation (2017-2027) ($MN)
  • Table 21 Global Tumor Ablation Market Outlook, By Catheters or Probes (2017-2027) ($MN)
  • Table 22 Global Tumor Ablation Market Outlook, By Application (2017-2027) ($MN)
  • Table 23 Global Tumor Ablation Market Outlook, By Liver cancer (2017-2027) ($MN)
  • Table 24 Global Tumor Ablation Market Outlook, By Prostate cancer (2017-2027) ($MN)
  • Table 25 Global Tumor Ablation Market Outlook, By Lung cancer (2017-2027) ($MN)
  • Table 26 Global Tumor Ablation Market Outlook, By Breast cancer (2017-2027) ($MN)
  • Table 27 Global Tumor Ablation Market Outlook, By Kidney cancer (2017-2027) ($MN)
  • Table 28 Global Tumor Ablation Market Outlook, By Bone Metastasis (2017-2027) ($MN)
  • Table 29 Global Tumor Ablation Market Outlook, By Brain Cancer (2017-2027) ($MN)
  • Table 30 Global Tumor Ablation Market Outlook, By Pancreatic Cancer (2017-2027) ($MN)
  • Table 31 Global Tumor Ablation Market Outlook, By Pain palliation (2017-2027) ($MN)
  • Table 32 Global Tumor Ablation Market Outlook, By ENT Cancer (2017-2027) ($MN)
  • Table 33 Global Tumor Ablation Market Outlook, By End User (2017-2027) ($MN)
  • Table 34 Global Tumor Ablation Market Outlook, By Oncology Clinics (2017-2027) ($MN)
  • Table 35 Global Tumor Ablation Market Outlook, By Research Institutes (2017-2027) ($MN)
  • Table 36 Global Tumor Ablation Market Outlook, By Cancer Specialty Centers (2017-2027) ($MN)
  • Table 37 Global Tumor Ablation Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 38 Global Tumor Ablation Market Outlook, By Surgical and Ablation Centers (2017-2027) ($MN)
  • Table 39 Global Tumor Ablation Market Outlook, By Diagnostic Centres (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.